Keisuke Miyazawa Selected Research

Keisuke Miyazawa Research Topics

Disease

24	Neoplasms (Cancer) 09/2021 - 12/2002
9	Leukemia 07/2020 - 09/2003
8	Multiple Myeloma 01/2018 - 06/2006
7	Lung Neoplasms (Lung Cancer) 05/2022 - 09/2003
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2010 - 09/2003
6	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 01/2011
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2009 - 02/2002
4	Thrombocytopenia (Thrombopenia) 09/2010 - 01/2003
4	Anemia 09/2010 - 01/2005
3	Carcinogenesis 08/2013 - 08/2006
3	Colonic Neoplasms (Colon Cancer) 08/2013 - 06/2009
3	Hepatocellular Carcinoma (Hepatoma) 02/2012 - 02/2006
3	Refractory Anemia 09/2010 - 04/2003
3	Cytopenia 09/2010 - 10/2004
3	Infections 01/2010 - 04/2003
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2003 - 12/2002
2	Squamous Cell Carcinoma of Head and Neck 05/2022 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2016
2	Stomach Neoplasms (Stomach Cancer) 02/2011 - 02/2006
2	Aplastic Anemia (Anemia, Hypoplastic) 07/2008 - 11/2004
2	Primary Myelofibrosis (Myelosclerosis) 01/2007 - 04/2005
2	Splenomegaly 01/2007 - 01/2005
2	Mucormycosis 11/2003 - 09/2003
2	Thrombosis (Thrombus) 11/2003 - 09/2003
2	Autoimmune Diseases (Autoimmune Disease) 11/2003 - 04/2003
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2021
1	Endometrial Neoplasms (Endometrial Cancer) 04/2021
1	Necrosis 12/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Multiple Sclerosis 07/2019
1	Starvation 04/2018
1	Infertility (Sterility) 10/2016
1	Type 2 Diabetes Mellitus (MODY) 07/2015
1	Glioblastoma (Glioblastoma Multiforme) 11/2013

Drug/Important Bio-Agent (IBA)

11	Vitamin K 2 (Vitamin K2)IBA 03/2020 - 09/2003
10	3-aminophenoxazoneIBA 11/2013 - 07/2005
7	Bortezomib (Velcade)FDA Link 09/2021 - 03/2011
6	MacrolidesIBA 08/2021 - 02/2015
6	Clarithromycin (Biaxin)FDA LinkGeneric 12/2020 - 04/2012
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2018
5	Proteasome InhibitorsIBA 09/2021 - 07/2013
5	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 02/2015
5	Imatinib Mesylate (Gleevec)FDA Link 07/2020 - 01/2003
5	menatetrenoneIBA 09/2010 - 09/2003
4	Tyrosine Kinase InhibitorsIBA 08/2021 - 04/2018
4	Azithromycin (Zithromax)FDA LinkGeneric 08/2021 - 11/2016
4	Gefitinib (Iressa)FDA Link 07/2020 - 05/2015
3	Cytostatic AgentsIBA 01/2022 - 01/2018
3	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2021 - 04/2012
3	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 07/2005
3	Pharmaceutical PreparationsIBA 01/2020 - 03/2010
3	Proteins (Proteins, Gene)FDA Link 07/2015 - 07/2008
3	ATP dependent 26S protease (26S proteasome)IBA 05/2013 - 03/2011
3	Prednisolone (Predate)FDA LinkGeneric 01/2007 - 11/2002
2	Histone Deacetylase 6IBA 05/2022 - 09/2021
2	ricolinostatIBA 05/2022 - 09/2021
2	Drug CombinationsIBA 01/2022 - 01/2018
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 07/2019
2	Lapatinib (GW572016)FDA Link 01/2022 - 07/2019
2	abemaciclibIBA 06/2020 - 01/2018
2	Amino Acids FDA Link 04/2018 - 01/2016
2	Phosphotransferases (Kinase)IBA 05/2015 - 01/2005
2	UbiquitinIBA 02/2015 - 04/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2013 - 03/2010
2	JNK Mitogen-Activated Protein KinasesIBA 11/2013 - 03/2009
2	phenoxazineIBA 08/2013 - 01/2010
2	Hemoglobins (Hemoglobin)IBA 09/2010 - 07/2005
2	VitaminsIBA 12/2007 - 02/2006
2	Interferon-alpha (Interferon Alfa)IBA 11/2003 - 02/2002
2	Deferoxamine (Desferal)FDA LinkGeneric 11/2003 - 09/2003
2	Inosine Triphosphate (ITP)IBA 04/2003 - 04/2003
2	Immunoglobulin G (IgG)IBA 12/2002 - 11/2002
1	SphingosineIBA 01/2022
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2021
1	Alanine (L-Alanine)FDA Link 04/2021
1	Estrogen Receptor alphaIBA 04/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Lansoprazole (Prevacid)FDA LinkGeneric 12/2020
1	Proton Pump InhibitorsIBA 12/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	Therapeutic UsesIBA 07/2020
1	ribociclibIBA 06/2020
1	palbociclibIBA 06/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 07/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2019
1	CyclinsIBA 01/2018
1	Cyclin-Dependent Kinase 4IBA 01/2018
1	VimentinIBA 11/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2016
1	DNA-Binding Proteins (DNA Binding Protein)IBA 07/2015
1	PotassiumIBA 07/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2015

Therapy/Procedure

27	Therapeutics 08/2021 - 02/2002
8	Drug Therapy (Chemotherapy) 08/2021 - 08/2006
5	Aftercare (After-Treatment) 10/2011 - 11/2004
2	Chemoprevention 03/2020 - 03/2011
2	Splenectomy 01/2005 - 12/2002